Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Clin Infect Dis ; 33(12): 2061-7, 2001 Dec 15.
Article in English | MEDLINE | ID: mdl-11702291

ABSTRACT

We studied the clinical resistance to acyclovir of infections with varicella-zoster viruses (VZV) in patients with acquired immunodeficiency syndrome, and we correlated it to virologic analyses. Eleven patients with VZV infections (treated with acyclovir, 30 mg/kg/day, given intravenously, or 4 g/day, given orally) were included in the study because of the failure of 10 days of acyclovir therapy. Susceptibility of VZV isolates to acyclovir was tested using a plaque reduction assay to determine the 50% inhibitory concentration (IC(50)) of acyclovir and the SI(50) (IC(50) of the patient isolate/IC(50) of the reference strain) to acyclovir. The thymidine kinase (TK) gene, which supports the resistance, was sequenced on amplified products. Only 3 patients had a significant increase in the IC(50), as compared with the IC(50) of the reference strain (SI(50) of > or =4), and a mutation in the TK gene. For the other 8 patients, the clinical resistance was not confirmed by the virologic results: the SI(50) was < 4, and no mutation was detected in the TK gene. Because no acyclovir-resistant strain appeared during a shorter period of time, we suggest an increase in the duration of the treatment to 21 days before acyclovir resistance is suspected.


Subject(s)
Acyclovir/pharmacology , Antiviral Agents/pharmacology , HIV Infections/virology , Herpesvirus 3, Human/drug effects , Drug Resistance, Microbial , Herpesvirus 3, Human/isolation & purification , Humans , Microbial Sensitivity Tests , Phenotype , Retrospective Studies
2.
J Acquir Immune Defic Syndr ; 27(2): 99-104, 2001 Jun 01.
Article in English | MEDLINE | ID: mdl-11404530

ABSTRACT

A retrospective study was set up to investigate the frequency of zidovudine (ZDV)-resistant HIV-1 in infected newborns after ZDV prophylaxis in the French Perinatal Cohort study. Nucleotide sequence analysis was carried out from 34 infants' isolates and 18 maternal plasma samples. Mutations related to ZDV resistance were found in the HIV-1 reverse transcriptase in 7 of 34 children (20%). Evidence of mother-child transmission of ZDV-resistant HIV-1 was found in 4 cases. Phylogenetic analysis showed that 14 of 34 HIV-1 isolates from the infants belonged to non-B subtypes. The presence of ZDV resistance-encoding mutations in the newborn isolates was associated with a longer total duration of exposure to ZDV. In a context of a wide HIV-1 variability, ZDV resistance can be one of the factors contributing to mother-child transmission.


Subject(s)
Anti-HIV Agents/pharmacology , HIV Infections/virology , HIV-1/drug effects , HIV-1/genetics , Infectious Disease Transmission, Vertical/prevention & control , Reverse Transcriptase Inhibitors/pharmacology , Zidovudine/pharmacology , Anti-HIV Agents/therapeutic use , Cohort Studies , Drug Resistance, Microbial/genetics , Female , France , HIV Infections/prevention & control , HIV Reverse Transcriptase/genetics , HIV-1/classification , Humans , Infant, Newborn , Molecular Sequence Data , Pregnancy , Pregnancy Complications, Infectious/virology , RNA, Viral/blood , Retrospective Studies , Reverse Transcriptase Inhibitors/therapeutic use , Zidovudine/therapeutic use
4.
AIDS ; 6(10): 1187-93, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1466851

ABSTRACT

OBJECTIVES: To study the epidemiological trends, clinical patterns, evolution and prognosis of HIV infection in women. DESIGN: Cohort study of 1816 HIV-infected patients. RESULTS: Up to 1 January 1991, 483 (26.6%) of the patients reported to the Groupe d'Epidemiologie Clinique du SIDA en Aquitaine surveillance system were women. The male-to-female ratio has decreased progressively (3.4:1 in 1985; 2.7:1 in 1990) over time. Fifty per cent of HIV-infected women are or have been intravenous drug users (IVDU). The proportion of heterosexually acquired HIV infection increased from 11.6 to 34.6% over the last 5 years; 46.9% of the women infected through heterosexual intercourse reported sexual contacts with male IVDU. Excluding Kaposi's sarcoma, no significant difference was observed between men and women in the overall distribution of AIDS-defining events. The observed trend of a slower progression to AIDS in women, compared with men, disappeared when controlling for prognostic variables. However, female sex significantly enhanced survival after AIDS diagnosis in multivariate analysis (relative risk, 2.7; 95% confidence interval, 1.1-6.2). CONCLUSION: Early diagnosis of HIV infection in female patients and prevention of HIV infection among women is now a priority for public health interventions, both in industrialized and in developing countries.


Subject(s)
HIV Infections/epidemiology , AIDS-Related Opportunistic Infections/epidemiology , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/etiology , Adult , Cohort Studies , Demography , Female , France/epidemiology , HIV Infections/etiology , Humans , Male , Multivariate Analysis , Prognosis , Sex Factors , Sexually Transmitted Diseases, Viral/epidemiology , Sexually Transmitted Diseases, Viral/transmission , Substance Abuse, Intravenous/complications , Time Factors
8.
Presse Med ; 15(44): 2197-200, 1986 Dec 13.
Article in French | MEDLINE | ID: mdl-2949240

ABSTRACT

Three cases of subcutaneous fat necrosis of the newborn (SFNN) are presented. They occurred after a therapeutic coma induced by intravenous barbiturates to control convulsions unresponsive to conventional treatment. Two patients had widespread lesions. Histopathology showed prominent vascular involvement. Since 1970, 26 cases of SFNN have been published. Among the aetiological factors already described, hypothermia and ischaemia play a major role. It is suggested that brown adipose tissue might be of importance in the pathophysiology of subdural fat necrosis of the newborn.


Subject(s)
Fat Necrosis/physiopathology , Necrosis/physiopathology , Adipose Tissue, Brown/pathology , Barbiturates/adverse effects , Barbiturates/therapeutic use , Fat Necrosis/etiology , Female , Humans , Infant, Newborn , Male , Seizures/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL